Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
FluGaurd versus Vaxigrip in healthy adults for prevention of seasonal influenza
IRCT20080901001165N61Phase 3Completed
- Sponsor
- Nivad Pharmed Salamat
- Start
- Aug 2020
- Modality
- Small Molecules, Vaccines & Immunotherapeutics
- Countries
- 1
01
Overview
Phase 3 trial of favipiravir and influenza vaccine in seasonal influenza (2 arms), sponsored by Nivad Pharmed Salamat. Primary endpoints: Geometric mean titer ratio for hemagglutinin antibodies and Seroconversion rate difference. Started Aug 2020; status: completed.
02
Drugs
favipiravirinfluenza vaccine
03
Conditions
seasonal influenza
Beyond the preview
Go deeper on IRCT20080901001165N61.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT20080901001165N61.